. . . . . . . "[Mean survival of diffuse astrocytoma patients with PDGFRA gain was 8.8 � 1.6 years, similar to that with IDH1/2 mutations (7.8 � 0.5 years) or TP53 mutations (7.6 � 0.6 years) but significantly longer than those with MET gain (4.4 � 0.7 years).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:15+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .